Toby Freyman

Toby Freyman is an accomplished executive in the pharmaceutical and biotechnology sectors, currently serving as Vice President of Business Development at Alexion Pharmaceuticals, Inc. since March 2024. Previously, Toby held key leadership roles at BeiGene, Takeda, Shire, Arsenal Medical, CRA International, and Boston Scientific Corporation, contributing expertise in business development and strategic marketing across various functions, including rare diseases and genetic disorders. Toby's educational background includes a Ph.D. in Materials Engineering from the Massachusetts Institute of Technology and a BS in Engineering Physics from Syracuse University, supplemented by study at City, University of London.